Free Trial

CVS Group (LON:CVSG) Sets New 12-Month High - Time to Buy?

CVS Group logo with Consumer Cyclical background

Key Points

  • Shares of CVS Group plc reached a new 52-week high, trading at GBX 1,374 ($18.52) and closing at GBX 1,362 ($18.36).
  • Analysts have a consensus "Buy" rating for CVS Group, with price targets ranging from GBX 1,500 to GBX 2,000.
  • CVS Group reported a quarterly EPS of GBX 80.10 and is expected to post earnings of 93.94 per share for the current year.
  • Interested in CVS Group? Here are five stocks we like better.

Shares of CVS Group plc (LON:CVSG - Get Free Report) hit a new 52-week high during trading on Tuesday . The company traded as high as GBX 1,374 ($18.52) and last traded at GBX 1,362 ($18.36), with a volume of 235458 shares traded. The stock had previously closed at GBX 1,250 ($16.85).

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on CVSG. Royal Bank Of Canada reiterated an "outperform" rating and issued a GBX 1,500 price target on shares of CVS Group in a report on Friday, August 29th. Berenberg Bank reaffirmed a "buy" rating and set a GBX 2,000 target price on shares of CVS Group in a research report on Tuesday, September 2nd. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat, CVS Group has a consensus rating of "Buy" and an average price target of GBX 1,750.

Read Our Latest Stock Analysis on CVS Group

CVS Group Stock Performance

The company has a debt-to-equity ratio of 110.52, a current ratio of 1.09 and a quick ratio of 0.90. The company has a market cap of £988.58 million, a PE ratio of 36,263.16, a price-to-earnings-growth ratio of 1.77 and a beta of 1.02. The business has a fifty day simple moving average of GBX 1,235.56 and a two-hundred day simple moving average of GBX 1,191.40.

CVS Group (LON:CVSG - Get Free Report) last released its quarterly earnings results on Tuesday, October 7th. The company reported GBX 80.10 EPS for the quarter. CVS Group had a return on equity of 7.86% and a net margin of 3.20%. Research analysts anticipate that CVS Group plc will post 93.9393939 earnings per share for the current year.

Insider Buying and Selling

In other news, insider Richard Fairman purchased 1,644 shares of the firm's stock in a transaction on Friday, July 11th. The stock was acquired at an average cost of GBX 1,216 per share, with a total value of £19,991.04. Corporate insiders own 1.38% of the company's stock.

About CVS Group

(Get Free Report)

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CVS Group Right Now?

Before you consider CVS Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Group wasn't on the list.

While CVS Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.